FACTORS DETERMINING BONE MINERAL DENSITY LOSS IN CHRONIC HEPATITIS B PATIENTS: IS TENOFOVIR DISOPROXIL FUMARATE THE MAIN CULPRIT?

被引：3
|
作者：
Gill, U. S. [1 ]
Al-Shamma, S. [1 ]
Burke, K. [1 ]
Ross, V. [1 ]
Kooner, P. [1 ]
Marley, R. [1 ]
Foster, G. R. [1 ]
Kennedy, P. T. F. [1 ]
机构：
[1] Barts & London Queen Marys Sch Med & Dent, London, England
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
10.1016/S0168-8278(11)60715-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
713
引用
收藏
页码：S286 / S286
页数：1
相关论文
共 50 条
  • [31] Predictors of HBeAg loss in HBeAg-positive patients with chronic hepatitis B during treatment with tenofovir alafenamide or tenofovir disoproxil fumarate
    Flaherty, J.
    Kim, K.
    Jackson, A.
    Myers, R.
    Subramanian, M.
    Agarwal, K.
    Kong, M. Kin
    Lee, K. S.
    Balabanska, R.
    Ma, M.
    Pan, C.
    Abdurakhmanov, D.
    Bae, H.
    HIV MEDICINE, 2017, 18 : 42 - 43
  • [32] Reduced Changes In Bone Mineral Density In CHB Patients Receiving Tenofovir Alfenamide (TAF) Compared With Tenofovir disoproxil fumarate
    Seto, Wai-Kay
    Asahina, Yasuhiro
    Peng, Cheng-Yuan
    Stanciu, Carol
    Abdurakhmanov, Djamal
    Flaherty, John F.
    Kim, Kyungpil
    Gaggar, Anuj
    Subramanian, Mani
    Tabak, Fehmi
    Nguyen, Tuan T.
    Chan, Henry Lik-Yuen
    HEPATOLOGY, 2016, 64 : 35A - 35A
  • [33] From Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF): Perspectives in Pediatric Patients with Chronic Hepatitis B
    Rodrigo, Minna
    Hartley, Christopher
    Wasuwanich, Paul
    Van, Trung
    Karnsakul, Wikrom
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (12) : 1099 - 1106
  • [34] Comparable risk of cardiovascular events in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
    Hong, Hyeyeon
    Choi, Jonggi
    Choi, Won-Mook
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1139 - S1139
  • [35] Reply to correspondence on "Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide"
    Cheng, Pin-Nan
    Yu, Ming-Lung
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (04)
  • [36] Changes in bone mineral density during monotherapy with tenofovir disoproxil fumarate: a 6-year real life longitudinal cohort study in chronic hepatitis B caucasian patients
    Vigano, M.
    Loglio, A.
    Cerini, F.
    Farina, E.
    Facchetti, F.
    Perbellini, R.
    Rumi, M. G.
    Lampertico, P.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : E27 - E27
  • [37] FACTORS PREDICTIVE OF IMPROVEMENT OF RENAL FUNCTION AFTER SWITCHING TO TENOFOVIR ALAFENAMIDE FROM TENOFOVIR DISOPROXIL FUMARATE IN PATIENTS WITH CHRONIC HEPATITIS B
    Hong, Hyeyeon
    Choi, Won-Mook
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Choi, Jonggi
    HEPATOLOGY, 2024, 80 : S242 - S243
  • [38] Comparison of lipid profile alterations in chronic hepatitis b patients receiving tenofovir alafenamide or tenofovir disoproxil fumarate
    Lin, Shenglong
    Huang, Wanlong
    Liao, Ziyuan
    Ma, Huaxi
    Wu, Wenjun
    Lin, Minghua
    Huang, Defu
    Gao, Haibing
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [39] Tenofovir disoproxil fumarate for patients with chronic hepatitis B who suboptimal response to non-tenofovir disoproxil fumarate nucleos(t)ide analogs therapy
    Chen, Kwei-Ming
    Chang, Chi-Hsien
    Lee, Jyong-Hong
    Yang, Chi-Chieh
    ADVANCES IN DIGESTIVE MEDICINE, 2020, 7 (04) : 207 - 213
  • [40] Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B
    Beatriz Mateos-Muñoz
    María Buti
    Inmaculada Fernández Vázquez
    Marta Hernández Conde
    Vanesa Bernal-Monterde
    Fernando Díaz-Fontenla
    Rosa María Morillas
    Luisa García-Buey
    Ester Badía
    Mireia Miquel
    Alberto Amador-Navarrete
    Sergio Rodríguez-Tajes
    Lucía Ramos-Merino
    Antonio Madejón
    Montserrat García-Retortillo
    Juan Ignacio Arenas
    Joaquín Cabezas
    Jesús Manuel González Santiago
    Conrado Fernández-Rodríguez
    Patricia Cordero
    Moisés Diago
    Antonio Mancebo
    Alberto Pardo
    Manuel Rodríguez
    Elena Hoyas
    Jose Javier Moreno
    Juan Turnes
    Miguel Ángel Simón
    Cristina Marcos-Fosch
    Jose Luis Calleja
    Rafael Bañares
    Sabela Lens
    Javier Garcia-Samaniego
    Javier Crespo
    Manuel Romero-Gomez
    Francisco Gea
    Enrique Rodríguez de Santiago
    Santiago Moreno
    Agustin Albillos
    Digestive Diseases and Sciences, 2023, 68 : 2731 - 2737
12345